Home > Boards > US OTC > Medical - Healthcare >

BioCorRx Inc. (BICX)

BICX RSS Feed
Add BICX Price Alert      Hide Sticky   Hide Intro
Moderator: Pip611, 236T568
Search This Board: 
Last Post: 4/18/2019 10:40:58 AM - Followers: 145 - Board type: Free - Posts Today: 0

 

 

About BioCorRx

Program Overview

BioCorRx (OTCBB: BICX) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a treatment program that is used by various licensed alcohol addiction clinics throughout the United States.

The program consists of two components:BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant formulation of the FDA-approved drug, naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol for as long as a year in some patients, depending on individual metabolism rates.BioCorRx also owns a life coaching program that is tailored specifically to alcoholics. Once a patient has received the implant, they are encouraged to enter the life coaching program to maximize results.

BioCorRx’s revolutionary alcohol treatment program has an 85% success rate as reported by patients in routine telephone and face to face interviews. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life coaching program without co-workers or family members knowing, unless they so choose.

Technology

Naltrexone is a medication that blocks the effects of drugs known as opioids and was approved by the FDA in 1995 for the treatment of alcohol dependence.

Learn more about the side effects of naltrexone.

Naltrexone blocks the parts of the brain that "feel pleasure” when patients use alcohol. When these areas of the brain are blocked, patients feel significantly less cravings for alcohol and even if alcohol is used, the effects of it will be extremely limited - making sobriety the only option. Once medical intervention has reduced the physical need for alcohol, the program goes on to address the patient's psychological needs. The combination of these treatments has resulted in the highest chance of sobriety.

naltrexone implant

While other companies use naltrexone in their treatments, the drug is typically administered in oral or injection form, requiring their patients to be responsible for taking the medication or scheduling an appointment.

While some patients do well with the oral formulation, there is a drawback that it must be taken daily and a patient whose craving becomes overwhelming can obtain the euphoria simply by skipping a dose before resuming abuse. Patients who received the program developed by BioCorRx are treated with a slow release dose that can last up to year in many patients (depending on various factors such as metabolism rates), which gives the patients a higher success rate for the treatment of alcoholism.

The outpatient naltrexone implant procedure can take as little as 20 minutes under local anesthetic in some cases. Most patients can return to work or their daily routine in the same day, without the cravings for alcohol.

Mission, Vision, Values

Mission

BioCorRx is focused on providing leadership and innovation for the treatment of alcoholism by offering a high-quality, comprehensive and cost-effective recovery program that allows patients and their loved ones to celebrate freedom from the cycle of alcohol addiction. Our program is built on a strong foundation of experience and practice, allowing for an improved quality of life for recovering alcoholics.

Vision

BioCorRx strives to be the preeminent, long-term alcohol recovery program used by treatment centers around the world for alcoholics, as well as their family and friends. By providing patients a "Fresh Start" on life, they have the opportunity to live happier, healthier, more productive lives away from the damaging impact of alcohol. We have built an organization that is committed to nurturing research for cutting-edge alcohol recovery technologies and integrating those technologies with comprehensive alcohol recovery treatment programs.

Values

BioCorRx provides the opportunity and tools to treatment centers so they can help patients live happier, healthier, and more productive lives to those suffering from alcohol addiction (as well as their family and friends) by helping them break the addiction cycle and live alcohol-free. We want patients to celebrate freedom from the past and hope for the future. Our team consists of physicians, coaches, founders and management that are committed to providing high-quality services and adherence to ethical care.

Our goal is to give our treatment center partners the ability to deliver our program in a timely, warm and compassionate way to give patients, as well as their families and friends, peace of mind. To achieve this, BioCorRx has built its program around highly-qualified alcohol addiction specialists and effective treatment solutions.

We are committed to quality and continuous improvement in order to meet our partners’ needs for an individualized program dedicated to alcohol addiction recovery.

Investors Overview

BioCorRx is uniquely poised to gain significant market share of the $22 billion annual alcohol treatment market in the US.

More than 7% of the US population ages 18 years and older or 13.8 million Americans have problems with drinking, including 8.1 million people who suffer from alcoholism. And the costs financially are staggering. Alcohol dependency and abuse costs the US over $220 billion a year. For the sake of comparison, this is greater than the amount of money spent to combat cancer ($196 billion) and obesity ($133 billion).

BioCorRx intends to distribute the program to a new clinic in the United States every 60 to 90 days. Clinics using our program are also holding discussions with major health insurance providers to pay for all or a portion of the treatment fees.

Business Model

BioCorRx’s research has discovered that demand for its services are high and that growth in highly marketed segments of the population may be achieved through partnering with additional clinic sites. The company is also exploring the sub-licensing of the program to select regions of the US and internationally.

BioCorRx's goal is to meet its growth targets through licensing opportunities by promoting its naltrexone implant product and counseling service model to existing medical clinics and treatment centers that will purchase the program and/or product from the company. In addition, Fresh Start Private intends to open corporately owned clinics in select key markets where it is deemed appropriate.

Stock Price & Charts

BioCorRx is a fully reporting company. Financial reports and other reports are available for view or by visiting the OTCBB.com online website. Audited financial reports are available quarterly.

Company Structure Details

  • Legal name: BioCorRx
    Sector: Healthcare
    Industry: Specialized Health Services
    Full Time Employees: 4
    Public Company: SEC Reporting and fully audited
    Symbol: BICX
    Exchange: OTCBB
    Outstanding: 117,800,000
    Authorized: 200,000,000
    CUSIP: 35804J102
    NAICS Code: 623220
    SIC Number: 8093
    Transfer Agent: Columbia Stock Transfer Company, 1869 E. Seltice Way #292, Post Falls, ID 83854 Tel (208) 664-3544
    CIK: 0001443863
    EIN: 26-1972677
    Year End: December 31
    State of incorporation: Nevada
    Products: Alcohol rehabilitation, exclusive naltrexone implant technology
    Address: 601 North Parkcenter Drive, Suite 103, Santa Ana, CA 92705 USA
    Investors: 858-381-4677
    Email: investors@biocorrx.com
    Website: www.biocorrx.com
Watch Jeremy Miller on Fox News!
https://www.youtube.com/watch?v=kVKgWi3_t5Y

<iframe width="560" height="315" src="; frameborder="0" allowfullscreen></iframe>www.youtube.com/embed/xhJrYqsV0VQ

<iframe width="560" height="315" src="https://www.youtube.com/watch?v=kVKgWi3_t5Y" frameborder="0" allowfullscreen></iframe>


 

BICX Chart

Key Executives

Kent Emry - CEO, Director
Brady Granier -COO, Director
Lourdes Felix -CFO, Director
Dr. Jorge Andrade, Jr. - Director
Neil Muller -Co-Founder and President, Director 

Locations
Locations of independently owned clinics using our Fresh Start Program

Start Fresh Recovery
720 N. Tustin Ave.
Suite 206
Santa Ana, CA 92705
714-541-6100
800-916-1099
www.startfreshrecovery.com 
www.stopdrinkingUSA.com

Start Fresh Executive Recovery
367 E Virginia Ave
Phoenix, AZ 85004
855-393-HOPE (4673)
www.ExecutiveRecovery.net 

Fresh Start Private Florida
1415 Panther Lane
Suites 313-320
Naples, FL 34109
800-985-7574
www.FreshStartPrivateFlorida.com 

Start Fresh Alcohol Recovery Center
2827 S. 88th St
Omaha NE 68124
402-884-1221
www.startfreshNE.com

Coming Soon!

• San Francisco, California
• Chandler, Arizona
• North Scottsdale, Arizona
• Connecticut

Insider Interview Links

December 2, 2013 - thewallstreetanalyzer.com Interview with Brady Granier COO
November 14, 2013 - SmallCapVoice Interview with Kent Emry CEO
October 2, 2013 - SmallCapVoice Interview with Brady Granier COO

 

 

BICX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#12199  Sticky Note Scam company BICX issues FALSE AND MISLEADING press 236T568 04/11/19 02:46:18 PM
#7544  Sticky Note VIVITROL is injectable naltrexone produced by Alkermes plc Pip611 09/09/16 05:15:47 PM
#12281   Scam company BICX issues FALSE AND MISLEADING press 236T568 04/18/19 12:37:39 AM
#12280   Looks like a long time believer in BICX! telark 04/18/19 12:34:05 AM
#12279   Oh My... Go BICX!!!! telark 04/18/19 12:31:50 AM
#12278   Go BICX!! telark 04/18/19 12:29:36 AM
#12277   Oh My... telark 04/18/19 12:29:20 AM
#12276   GO BICX! telark 04/18/19 12:29:01 AM
#12275   Oh my telark 04/18/19 12:28:37 AM
#12269   Oh my... telark 04/17/19 05:17:50 PM
#12268   Oh my! $5.35 low today! 236T568 04/17/19 04:10:16 PM
#12266   Could you please direct me to a pharmaceutical Leshrac528 04/16/19 01:36:12 PM
#12263   BICX Massive Net Loss of $6.5 million for 2018 236T568 04/16/19 10:56:49 AM
#12262   BICX 2018 Revenues DROP by 43% to only 236T568 04/16/19 10:53:38 AM
#12261   BICX 4th QTR Revenues DROP by 69% to 236T568 04/16/19 10:51:11 AM
#12260   BICX files 10K with SEC for the year 236T568 04/16/19 10:49:19 AM
#12259   BioCorRx Inc.FORM 10-K Brentley 04/16/19 08:31:57 AM
#12258   Great call Fido! BICX recently closed $6MM Stock62 04/15/19 11:09:46 PM
#12256   Old info come up with something new and original. Admtiger 04/15/19 05:28:54 PM
#12254   actually, wrong 236T568 04/15/19 05:25:54 PM
#12252   Completely incorrect. telark 04/15/19 04:52:13 PM
#12251   BICX recently closed $6,000,000 equity financing, Go BICX!!!!!!!!!!!!!! telark 04/15/19 04:50:23 PM
#12248   BICX signs $10 million deep discount death spiral 236T568 04/15/19 04:15:14 PM
#12245   Scam company BICX issues FALSE AND MISLEADING press 236T568 04/15/19 03:10:00 PM
#12244   Go get em Fido!! stanggt 04/15/19 03:03:04 PM
#12243   actually, at 5.75 the stock price of scam 236T568 04/15/19 03:02:35 PM
#12242   actually the stock price of scam company BICX 236T568 04/15/19 02:54:12 PM
#12241   Fido, I agree! This is great!!! The climb BanOxy 04/15/19 02:51:29 PM
#12240   Oh my...and way down from Friday's close 236T568 04/15/19 02:51:13 PM
#12239   $5.75 and climbing - as the recovery continues!! Fido 04/15/19 02:18:59 PM
#12238   So as the stock price of company BICX Fido 04/15/19 02:18:10 PM
#12237   Price rising into EOD. Fido 04/15/19 02:17:12 PM
#12236   A total disaster for shorts coming soon! Fido 04/15/19 02:16:35 PM
#12235   $5.75 high of the day. Fido 04/15/19 02:15:41 PM
#12234   OUCH, price climbing, someone knows something. Shorts Fido 04/15/19 02:14:28 PM
#12233   $5.30 and dropping - as the total price 236T568 04/15/19 10:11:29 AM
#12232   This company has some solid bones yet I telark 04/15/19 02:51:39 AM
#12227   So as the stock price of scam company 236T568 04/12/19 04:22:16 PM
#12225   $5.90 and dropping - as the b/a drops 236T568 04/12/19 02:53:58 PM
#12224   A total disaster coming by Tuesday April 16, 236T568 04/12/19 02:23:11 PM
#12223   $6.06 low so far today! 236T568 04/12/19 02:13:57 PM
#12222   Ouch! $6.15 as b/a drops to $5.95/$6.10 236T568 04/12/19 01:59:17 PM
#12221   Thank you so much! Lol Joshthebeast24 04/12/19 01:14:15 PM
#12220   If you go to their profile, you can Thomasthomas 04/12/19 10:46:31 AM
#12215   actually, THIS is exactly what you said: 236T568 04/11/19 05:28:29 PM
#12214   Integral, this is all you have to read 236T568 04/11/19 05:22:36 PM
#12213   I said, and I’ll say it again... the Kizersosae 04/11/19 05:20:48 PM
#12212   So tell us, which one of these TWO 236T568 04/11/19 05:14:47 PM
#12211   What you point is that BICX is high Kizersosae 04/11/19 05:04:11 PM
#12209   You question doesn’t speak volume... because: #1 they haven’t Kizersosae 04/11/19 04:42:26 PM
#12208   I will counter. While they may or integral 04/11/19 04:38:21 PM
#12207   Half? And many of these agreements "put", integral 04/11/19 04:33:45 PM
PostSubject